Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock
NCT06072430Phase 3Completed
- Sponsor
- Vivacelle Bio
- Start
- Aug 2024
- Primary completion
- Jun 2026
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of VBI-S in septic shock, hypovolemia, sponsored by Vivacelle Bio. Started Aug 2024; status: completed.
02
Drugs
VBI-S
03
Conditions
septic shockhypovolemia
Beyond the preview
Go deeper on NCT06072430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06072430.